UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3094) 3094
Book Chapter (10) 10
Book / eBook (9) 9
Magazine Article (4) 4
Conference Proceeding (1) 1
Newsletter (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2310) 2310
science & technology (2182) 2182
life sciences & biomedicine (2041) 2041
male (1703) 1703
female (1599) 1599
middle aged (1141) 1141
organometallic compounds - adverse effects (1017) 1017
adult (960) 960
animals (919) 919
aged (877) 877
organometallic compounds - therapeutic use (786) 786
organometallic compounds (681) 681
organometallic compounds - administration & dosage (650) 650
radiology, nuclear medicine & medical imaging (558) 558
magnetic resonance imaging (422) 422
treatment outcome (397) 397
organometallic compounds - pharmacology (371) 371
contrast media (364) 364
rats (317) 317
adolescent (308) 308
gadolinium (304) 304
aged, 80 and over (296) 296
contrast media - adverse effects (275) 275
organometallic compounds - toxicity (274) 274
abridged index medicus (271) 271
time factors (269) 269
prospective studies (254) 254
meglumine - adverse effects (253) 253
organometallic compounds - chemistry (244) 244
pharmacology & pharmacy (238) 238
medicine & public health (235) 235
organometallic compounds - pharmacokinetics (221) 221
mice (220) 220
gastroenterology & hepatology (219) 219
oncology (218) 218
magnetic resonance imaging - methods (215) 215
dose-response relationship, drug (213) 213
toxicology (208) 208
contrast media - administration & dosage (199) 199
child (195) 195
gadolinium dtpa (186) 186
physical sciences (173) 173
chemistry (171) 171
drug therapy, combination (170) 170
care and treatment (163) 163
young adult (163) 163
biochemistry & molecular biology (159) 159
meglumine - administration & dosage (159) 159
research (158) 158
retrospective studies (156) 156
risk factors (156) 156
helicobacter infections - drug therapy (155) 155
analysis (150) 150
health aspects (143) 143
meglumine - analogs & derivatives (139) 139
cardiovascular system & cardiology (135) 135
meglumine - therapeutic use (133) 133
antiprotozoal agents - adverse effects (130) 130
child, preschool (127) 127
toxicity (126) 126
imaging / radiology (123) 123
thiophenes - therapeutic use (118) 118
administration, oral (116) 116
antiprotozoal agents - therapeutic use (116) 116
leishmaniasis, cutaneous - drug therapy (116) 116
double-blind method (115) 115
drug therapy (114) 114
cardiac & cardiovascular systems (112) 112
reproducibility of results (111) 111
sensitivity and specificity (111) 111
helicobacter pylori (110) 110
cancer (109) 109
rats, wistar (107) 107
drug combinations (106) 106
general & internal medicine (106) 106
drug administration schedule (105) 105
endocrinology & metabolism (105) 105
injections, intravenous (105) 105
gadolinium - adverse effects (102) 102
predictive value of tests (102) 102
medicine (101) 101
medicine, general & internal (101) 101
meglumine antimoniate (101) 101
internal medicine (99) 99
anti-bacterial agents - therapeutic use (98) 98
cathartics - adverse effects (97) 97
octreotide - analogs & derivatives (95) 95
usage (94) 94
disease models, animal (93) 93
safety (93) 93
pentetic acid - adverse effects (92) 92
osteoporosis (91) 91
radionuclide imaging (91) 91
surgery (91) 91
bone density conservation agents - therapeutic use (90) 90
follow-up studies (89) 89
organometallic compounds - metabolism (88) 88
pentetic acid - analogs & derivatives (88) 88
patients (87) 87
osteoporosis, postmenopausal - drug therapy (86) 86
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2946) 2946
French (43) 43
German (41) 41
Russian (39) 39
Portuguese (37) 37
Japanese (35) 35
Spanish (33) 33
Chinese (11) 11
Italian (11) 11
Dutch (9) 9
Polish (5) 5
Czech (2) 2
Danish (2) 2
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigational new drugs, ISSN 1573-0646, 10/2014, Volume 33, Issue 1, pp. 201 - 214
Background This phase I/II study determined the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics of ruthenium compound NAMI... 
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2015, Volume 74, Issue 11, pp. 2062 - 2069
Journal Article
Calcified tissue international, ISSN 0171-967X, 8/2011, Volume 89, Issue 2, pp. 91 - 104
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of nuclear medicine (1978), ISSN 0161-5505, 06/2014, Volume 55, Issue 8, pp. 1248 - 1252
Journal Article
European journal of nuclear medicine and molecular imaging, ISSN 1619-7089, 2008, Volume 35, Issue 4, pp. 756 - 765
...®) is indicated for the prevention of skeletal complications. Because of the different therapeutic effects, combining the treatments may be beneficial... 
Zoledronic acid | Pain | Samarium | Bone metastases | Nuclear therapy | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Prostatic Neoplasms - radiotherapy | Radioisotopes - pharmacokinetics | Injections, Intravenous | Humans | Bone Neoplasms - secondary | Male | Metabolic Clearance Rate | Neoplasm Metastasis | Samarium - therapeutic use | Samarium - pharmacokinetics | Samarium - adverse effects | Diphosphonates - therapeutic use | Organometallic Compounds - therapeutic use | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Diphosphonates - adverse effects | Prostatic Neoplasms - pathology | Organophosphorus Compounds - adverse effects | Radioisotopes - therapeutic use | Bone Density Conservation Agents - adverse effects | Organometallic Compounds - adverse effects | Imidazoles - adverse effects | Radioisotopes - adverse effects | Organophosphorus Compounds - therapeutic use | Bone Density Conservation Agents - therapeutic use | Organometallic Compounds - pharmacokinetics | Combined Modality Therapy | Samarium - administration & dosage | Bone Neoplasms - radiotherapy | Radioisotopes - administration & dosage | Organophosphorus Compounds - administration & dosage | Organophosphorus Compounds - pharmacokinetics | Organometallic Compounds - administration & dosage | Care and treatment | Cancer patients | Metastasis | Prostate cancer | Drug interactions | Nuclear medicine | Bone cancer | Pharmacology | Radiation therapy | Clinical outcomes | Pharmaceuticals | Index Medicus | Original
Journal Article